Stockholm Medical Cannabis Conference

Five arguments for, and one argument against, renaming the Endocannabinoid System

In this blog post, the author presents five reasons to consider changing the name of the endocannabinoid system (ECS) and one reason to keep its current name. The author argues that the name of the ECS does not accurately represent its natural and integral part of our biology. The name limits our understanding of its potential therapeutic applications, ignores its complexity and diversity of components, and hinders its public acceptance and incorporation into medical education. The author suggests a more precise and comprehensive name that would better represent the diverse interactions that happen within the ECS.

The Missing Chapter: How Human Physiology Textbooks Fail to Include the Endocannabinoid System

The endocannabinoid system (ECS) is a complex network of receptors, ligands, and enzymes that modulates various physiological processes in the human body. However, despite its critical role in human health and disease, the ECS and its components have not been adequately included in many popular medical textbooks, such as the ‘Guyton and Hall Textbook of Medical Physiology’. This article highlights the importance of incorporating the ECS and its therapeutic potential into medical education, as most doctors are not trained in the ECS and consequently have inadequate knowledge about the potential therapeutic uses of medical cannabis.